Psychedelic effects of a subanesthetic concentration of nitrous oxide. 1990

R I Block, and M M Ghoneim, and V Kumar, and D Pathak
Department of Anesthesia, University of Iowa, Iowa City.

The subjective effects of nitrous oxide were examined by administering questionnaires to volunteers (16 men and 16 women) breathing 30% nitrous oxide or 100% oxygen. Nitrous oxide produced a variety of subjective effects, including some that are characteristic of psychedelic drugs, such as happy, euphoric mood changes, changes in body awareness and image, alterations of time perception, and experiences of a dreamy, detached reverie state. The subjective effects, including those of a psychedelic nature, were very similar to the subject effects we observed in a previous study of nitrous oxide. However, euphoric mood changes were more pronounced, and adverse effects were less pronounced, in the present study, possibly due to the shorter duration of gas inhalation or the minimal tests of performance involved. Some other differences in subjective effects between the present and previous studies were identified by a discriminant analysis and seemed related to specific differences in experimental conditions. This suggests that the environment can influence which drug effects emerge, or at least their relative prominence. Clinicians should be familiar with the range of subjective effects that patients inhaling nitrous oxide may experience.

UI MeSH Term Description Entries
D008297 Male Males
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D001828 Body Image Individuals' concept of their own bodies. Body Identity,Body Representation,Body Schema,Body Images,Body Representations,Body Schemas,Identity, Body,Image, Body,Representation, Body,Schema, Body
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004325 Dreams A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state. Nightmares,Dream,Nightmare
D004777 Environment The external elements and conditions which surround, influence, and affect the life and development of an organism or population. Environmental Impact,Environmental Impacts,Impact, Environmental,Impacts, Environmental,Environments
D005059 Euphoria An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. Euphorias
D005260 Female Females
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic

Related Publications

R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1981, Progress in neuro-psychopharmacology,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
February 2009, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
December 1978, Anesthesiology,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1991, Annals of the New York Academy of Sciences,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1993, Journal of vestibular research : equilibrium & orientation,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1995, Pharmacology, biochemistry, and behavior,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
November 1997, Anesthesiology,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
June 1989, Masui. The Japanese journal of anesthesiology,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1975, Eksperimental'naia khirurgiia i anesteziologiia,
R I Block, and M M Ghoneim, and V Kumar, and D Pathak
January 1962, Anesthesiology,
Copied contents to your clipboard!